BerGenBio ASA
BRRGF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $984 | $10 | $3 | $3 |
| - Cash | $66 | $66 | $140 | $175 |
| + Debt | $0 | $0 | $1 | $0 |
| Enterprise Value | $918 | -$56 | -$136 | -$172 |
| Revenue | $2 | $2 | $1 | $0 |
| % Growth | 0% | 246.8% | – | – |
| Gross Profit | $2 | $2 | $1 | $0 |
| % Margin | 100% | 100% | 100% | – |
| EBITDA | -$27 | -$27 | -$28 | -$23 |
| % Margin | -1,150.9% | -1,150.9% | -4,058.1% | – |
| Net Income | -$27 | -$27 | -$29 | -$25 |
| % Margin | -1,146% | -1,146% | -4,204% | – |
| EPS Diluted | -0.69 | -0.69 | -2.39 | -2.08 |
| % Growth | 0% | 71.1% | -14.9% | – |
| Operating Cash Flow | -$37 | -$37 | -$36 | -$28 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$37 | -$37 | -$36 | -$28 |